Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways.

El Fatimy R, Li S, Chen Z, Mushannen T, Gongala S, Wei Z, Balu DT, Rabinovsky R, Cantlon A, Elkhal A, Selkoe DJ, Sonntag KC, Walsh DM, Krichevsky AM.

Acta Neuropathol. 2018 Oct;136(4):537-555. doi: 10.1007/s00401-018-1880-5. Epub 2018 Jul 7.

2.

DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia.

Keller S, Punzo D, Cuomo M, Affinito O, Coretti L, Sacchi S, Florio E, Lembo F, Carella M, Copetti M, Cocozza S, Balu DT, Errico F, Usiello A, Chiariotti L.

Sci Rep. 2018 Jul 5;8(1):10163. doi: 10.1038/s41598-018-28332-x.

3.

Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.

Konopaske GT, Balu DT, Presti KT, Chan G, Benes FM, Coyle JT.

Schizophr Res. 2018 Nov;201:270-277. doi: 10.1016/j.schres.2018.04.042. Epub 2018 May 11.

PMID:
29759351
4.

The Role of Serine Racemase in the Pathophysiology of Brain Disorders.

Coyle JT, Balu DT.

Adv Pharmacol. 2018;82:35-56. doi: 10.1016/bs.apha.2017.10.002. Epub 2017 Nov 29.

5.

Astrocytes in primary cultures express serine racemase, synthesize d-serine and acquire A1 reactive astrocyte features.

Li S, Uno Y, Rudolph U, Cobb J, Liu J, Anderson T, Levy D, Balu DT, Coyle JT.

Biochem Pharmacol. 2018 May;151:245-251. doi: 10.1016/j.bcp.2017.12.023. Epub 2018 Jan 3.

PMID:
29305854
6.

Altered CREB Binding to Activity-Dependent Genes in Serine Racemase Deficient Mice, a Mouse Model of Schizophrenia.

Balu DT, Coyle JT.

ACS Chem Neurosci. 2018 Sep 19;9(9):2205-2209. doi: 10.1021/acschemneuro.7b00404. Epub 2017 Nov 27.

PMID:
29172439
7.

Serine Racemase and D-serine in the Amygdala Are Dynamically Involved in Fear Learning.

Balu DT, Presti KT, Huang CCY, Muszynski K, Radzishevsky I, Wolosker H, Guffanti G, Ressler KJ, Coyle JT.

Biol Psychiatry. 2018 Feb 1;83(3):273-283. doi: 10.1016/j.biopsych.2017.08.012. Epub 2017 Aug 26.

8.

Astroglial Versus Neuronal D-Serine: Check Your Controls!

Wolosker H, Balu DT, Coyle JT.

Trends Neurosci. 2017 Sep;40(9):520-522. doi: 10.1016/j.tins.2017.06.010. Epub 2017 Jul 26. No abstract available.

9.

Enhanced astrocytic d-serine underlies synaptic damage after traumatic brain injury.

Perez EJ, Tapanes SA, Loris ZB, Balu DT, Sick TJ, Coyle JT, Liebl DJ.

J Clin Invest. 2017 Aug 1;127(8):3114-3125. doi: 10.1172/JCI92300. Epub 2017 Jul 17.

10.

Cognitive Deficits in Prematurely Born Adults Are Associated With Reduced Basal Forebrain Integrity.

Balu DT.

Biol Psychiatry. 2017 Jul 15;82(2):e15-e16. doi: 10.1016/j.biopsych.2017.04.004. No abstract available.

11.

The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis.

Wolosker H, Balu DT, Coyle JT.

Trends Neurosci. 2016 Nov;39(11):712-721. doi: 10.1016/j.tins.2016.09.007. Epub 2016 Oct 11. Review.

12.

The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.

Balu DT.

Adv Pharmacol. 2016;76:351-82. doi: 10.1016/bs.apha.2016.01.006. Epub 2016 Mar 4. Review.

13.

History of the Concept of Disconnectivity in Schizophrenia.

Coyle JT, Balu DT, Puhl MD, Konopaske GT.

Harv Rev Psychiatry. 2016 Mar-Apr;24(2):80-6. doi: 10.1097/HRP.0000000000000102. Review.

14.

An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.

Balu DT, Li Y, Takagi S, Presti KT, Ramikie TS, Rook JM, Jones CK, Lindsley CW, Conn PJ, Bolshakov VY, Coyle JT.

Neuropsychopharmacology. 2016 Jul;41(8):2052-61. doi: 10.1038/npp.2016.2. Epub 2016 Jan 7.

15.

[JSNP Excellent Presentation Award for CINP2014].

Ishiwata S, Balu DT, Umino A, Coyle JT, Nishikawa T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2015 Apr;35(2):53-4. Japanese. No abstract available.

PMID:
26027070
16.

Neuronal serine racemase regulates extracellular D-serine levels in the adult mouse hippocampus.

Ishiwata S, Umino A, Balu DT, Coyle JT, Nishikawa T.

J Neural Transm (Vienna). 2015 Aug;122(8):1099-103. doi: 10.1007/s00702-015-1388-2. Epub 2015 Mar 18.

17.

Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.

Takagi S, Balu DT, Coyle JT.

Schizophr Res. 2015 Mar;162(1-3):216-21. doi: 10.1016/j.schres.2014.12.034. Epub 2015 Jan 12.

18.

The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond.

Balu DT, Coyle JT.

Curr Opin Pharmacol. 2015 Feb;20:109-15. doi: 10.1016/j.coph.2014.12.004. Epub 2014 Dec 23. Review.

19.

Chronic D-serine reverses arc expression and partially rescues dendritic abnormalities in a mouse model of NMDA receptor hypofunction.

Balu DT, Coyle JT.

Neurochem Int. 2014 Sep;75:76-8. doi: 10.1016/j.neuint.2014.05.015. Epub 2014 Jun 7.

20.

D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain.

Balu DT, Takagi S, Puhl MD, Benneyworth MA, Coyle JT.

Cell Mol Neurobiol. 2014 Apr;34(3):419-35. doi: 10.1007/s10571-014-0027-z. Epub 2014 Jan 17.

21.

D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI.

Santini MA, Balu DT, Puhl MD, Hill-Smith TE, Berg AR, Lucki I, Mikkelsen JD, Coyle JT.

Behav Brain Res. 2014 Feb 1;259:242-6. doi: 10.1016/j.bbr.2013.11.022. Epub 2013 Nov 20.

22.

Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.

Balu DT, Li Y, Puhl MD, Benneyworth MA, Basu AC, Takagi S, Bolshakov VY, Coyle JT.

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):E2400-9. doi: 10.1073/pnas.1304308110. Epub 2013 May 31.

23.

Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice.

Balu DT, Turner JR, Brookshire BR, Hill-Smith TE, Blendy JA, Lucki I.

Neuropharmacology. 2013 Apr;67:503-10. doi: 10.1016/j.neuropharm.2012.11.027. Epub 2012 Dec 6.

24.

Neuronal D-serine regulates dendritic architecture in the somatosensory cortex.

Balu DT, Coyle JT.

Neurosci Lett. 2012 May 31;517(2):77-81. doi: 10.1016/j.neulet.2012.04.020. Epub 2012 Apr 12.

25.

The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex.

Balu DT, Basu AC, Corradi JP, Cacace AM, Coyle JT.

Neurobiol Dis. 2012 Feb;45(2):671-82. doi: 10.1016/j.nbd.2011.10.006. Epub 2011 Oct 17.

26.

Depressive phenotypes evoked by experimental diabetes are reversed by insulin.

Ho N, Balu DT, Hilario MR, Blendy JA, Lucki I.

Physiol Behav. 2012 Feb 1;105(3):702-8. doi: 10.1016/j.physbeh.2011.09.003. Epub 2011 Sep 10.

27.

Glutamate receptor composition of the post-synaptic density is altered in genetic mouse models of NMDA receptor hypo- and hyperfunction.

Balu DT, Coyle JT.

Brain Res. 2011 May 25;1392:1-7. doi: 10.1016/j.brainres.2011.03.051. Epub 2011 Apr 12.

28.

Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function.

Balu DT, Carlson GC, Talbot K, Kazi H, Hill-Smith TE, Easton RM, Birnbaum MJ, Lucki I.

Hippocampus. 2012 Feb;22(2):230-40. doi: 10.1002/hipo.20887. Epub 2010 Nov 3.

29.

Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology.

DeVito LM, Balu DT, Kanter BR, Lykken C, Basu AC, Coyle JT, Eichenbaum H.

Genes Brain Behav. 2011 Mar;10(2):210-22. doi: 10.1111/j.1601-183X.2010.00656.x. Epub 2010 Nov 2.

30.

Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.

Balu DT, Coyle JT.

Neurosci Biobehav Rev. 2011 Jan;35(3):848-70. doi: 10.1016/j.neubiorev.2010.10.005. Epub 2010 Oct 15. Review.

31.
32.

Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments.

Balu DT, Hodes GE, Anderson BT, Lucki I.

Neuropsychopharmacology. 2009 Jun;34(7):1764-73. doi: 10.1038/npp.2008.234. Epub 2009 Jan 28.

33.

Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse.

Balu DT, Hodes GE, Hill TE, Ho N, Rahman Z, Bender CN, Ring RH, Dwyer JM, Rosenzweig-Lipson S, Hughes ZA, Schechter LE, Lucki I.

J Pharmacol Toxicol Methods. 2009 Mar-Apr;59(2):100-7. doi: 10.1016/j.vascn.2008.12.002. Epub 2008 Dec 14.

34.

Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology.

Balu DT, Lucki I.

Neurosci Biobehav Rev. 2009 Mar;33(3):232-52. doi: 10.1016/j.neubiorev.2008.08.007. Epub 2008 Aug 19. Review.

35.

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.

Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE, Lucki I.

Brain Res. 2008 May 23;1211:37-43. doi: 10.1016/j.brainres.2008.03.023. Epub 2008 Mar 21.

Supplemental Content

Support Center